Roman Campbell

Sempra (SRE) may enjoy gains as insiders got busy in the recent days

Roman Campbell

Sempra’s recently made public that its Chairman, CEO and President Martin Jeffrey W unloaded Company’s shares for reported $2.68 million ...

Taking a Closer Look At Janus Henderson Group plc (JHG) Following Its Recent Trade

Roman Campbell

Janus Henderson Group plc’s recent filing unveils that its CHIEF FINANCIAL OFFICER THOMPSON ROGER MJ unloaded Company’s shares for reported ...

Investing in Tronox Holdings plc (TROX): What You Must Know

Roman Campbell

In a filing, Tronox Holdings plc revealed its Director Johnston Peter acquired Company’s shares for reported $64200.0 on Aug 12 ...

GRAL stock rated an Equal-weight by Morgan Stanley

Roman Campbell

GRAIL Inc’s filing revealed that its President Ofman Joshua J. unloaded Company’s shares for reported $1.3 million on Dec 03 ...

Neurocrine Biosciences, Inc (NBIX) gets rating Initiated from Citigroup

Roman Campbell

Neurocrine Biosciences, Inc’s recently made public that its Director Norwalk Leslie V unloaded Company’s shares for reported $0.76 million on ...

Potential Price Increase for Opendoor Technologies Inc (OPEN) After Recent Insider Activity

Roman Campbell

Opendoor Technologies Inc’s recent filing unveils that its Officer Schaub Sydney acquired Company’s shares for reported $4.09 million on Nov ...

Recent Insider Activity Could Benefit Donaldson Co. Inc (DCI)

Roman Campbell

In a filing, Donaldson Co. Inc revealed its Former director WILLARD OBERTON acquired Company’s shares for reported $0.99 million on ...

Cytokinetics Inc [CYTK] Stock sold by Insider Callos Andrew for $0.9 million

Roman Campbell

Cytokinetics Inc’s filing revealed that its EVP, Chief Commercial Officer Callos Andrew unloaded Company’s shares for reported $0.9 million on ...

A Guide To The Risks Of Investing In Herbalife Ltd (HLF)

Roman Campbell

Herbalife Ltd’s recently made public that its Director L’Helias Sophie acquired Company’s shares for reported $10160.0 on Dec 01 ’25. ...

Investing in Century Therapeutics Inc (IPSC) Is Getting More Attractive

Roman Campbell

Century Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Cowan Chad acquired Company’s shares for reported $49252.0 on ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.